[PDF][PDF] 多灶性甲状腺乳头状癌的诊疗进展

孟庆东, 边学海, 孙辉 - 中国普通外科杂志, 2016 - zpwz.net
… ) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal
origin in distinct tumor foci[J].Cancer… with thyroid nodules and differentiated thyroid cancer[J]. …

血浆脂蛋白相关磷脂A2 水平早期预测进展性脑梗死的临床意义

杨山 - 蚌埠医学院学报, 2020 - xuebao.bbmu.edu.cn
… with PD98059 and PLX4032 induces sodium/ iodide symporter ( NIS) expression and
radioiodine uptake in BRAF mutated papillary thyroid cancer cells[ J]. Thyroid Res, 2018,11:13. …

Genetic alteration of Notch family members as a predicting factor for poor prognosis in papillary thyroid cancer/Notch 家族成员遗传学变异预示乳头状甲状腺癌高复发 …

Q Wei, Y Jia, C Pu, SHI Bing-yin - Xi'an jiao tong da xue xue …, 2018 - search.proquest.com
Objective: To verify the alterations of Notch family members (NOTCH1, NOTCH2, NOTCH3
and NOTCH4) in papillary thyroid cancer (PTC) samples to investigate the association …

甲状腺乳头状癌预防性中央区淋巴结清扫获得淋巴结数目的影响因素

刘克毅, 梁广芃, 柴芳, 刘畅 - 实用医学杂志, 2024 - syyxzz.com
… for papillary thyroid cancer, and to analyze the pattern of change so as to provide an important
basis for clinical treatment of papillary thyroid cancer… and BRAF gene V600E mutation(P > …

[PDF][PDF] 不同分型过敏性紫癜患者外周血Th1/Th2 型细胞因子的相关性研究

齐海花, 何磊, 黄占强, 丁华杰, 段昕所 - 河北医学, 2019 - hbyxzzs.cn
… Long noncoding RNA HOXA -AS2 promotes papillary thyroid cancer progression by regulating
miR-520c-3p/ S100A4 pathway[J].Cell Physiol Biochemꎬ2018ꎬ50(5): 1659~1672. [5] …

精确病理诊断在甲状腺癌精准医疗中的意义

陈健, 江亮 - 中国肿瘤临床, 2017 - cjco.cn
thyroid cancer, which could be divided into papillary thyroid cancer and follicular thyroid
cancer. The … between BRAF V600E mutation and mortality in patients with papillary thyroid

超声引导下细针穿刺细胞学联合BRAF V600E 基因突变检测对甲状腺乳头状癌的诊断及病情评估的研究进展

李若暄, 周祖邦 - 临床超声医学杂志, 2019 - lccscq.com
… for papillary thyroid cancer evaluating severity.This article reviews the research progress of
… V600E mutation on fine-needle aspiration cytology specimens in papillary thyroid cancer

BRAF 基因突变及医学超声在甲状腺结节中的临床价值研究

张旭旭 - 2021 - ir.lzu.edu.cn
… age of thyroid cancer group was 47.5 years (30-73 years);29 cases with positive BRAF
V600E mutation in thyroid cancer group, 21 cases with negative mutation;This mutation was not …

[HTML][HTML] 超声引导下细针穿刺洗脱液测定BRAFV600E突变丰度预测甲状腺乳头状癌颈部淋巴结转移

栾梦琪, 夏蜀珺, 林琳, 张桂萍… - 中华医学超声杂志 …, 2021 - chaosheng.cma-cmc.com.cn
… BRAF V600E mutation abundance determined based on ultrasound-guided fine needle
aspiration samples for predicting lymph node metastasis in papillary thyroid cancer[J]. Chinese …

BRAF V600E 突变对甲状腺乳头状癌发生及预后的影响

张婷婷, 渠宁, 史荣亮 - 中国癌症杂志, 2017 - china-oncology.com
… The clinicopathological features of BRAF mutated papillary thyroid cancers in Chinese
patients [J]. Int J Endocrinol, 2015, 2015: 642046. [15] KIM TY, KIM WB, RHEE YS, et al. …